2015 Poster Author Sessions

The AATOD Conference serves as a central gathering point for the opioid treatment community and offers significant opportunities for exhibiting companies and attendees to interact with other professionals who are devoted to the treatment of opioid dependence throughout the nation and abroad. The registrants will consist of the decision makers in this field who spend over $1 billion annually treating more than 325,000 patients in Opioid Treatment Programs. In order to provide exhibitors with steady exposure to conference attendees, all continental breakfasts and refreshment breaks will be held exclusively in the exhibit area. An Exhibitor’s Networking Event will be held Monday, March 30th to encourage contact and dialogue between opioid treatment professionals and the exhibiting companies.

Exhibit Hours
Sunday, March 29 4:00–7:30 p.m.
Monday, March 30 7:30–9:30 a.m.; 11:30 a.m.–4:30 p.m.
Tuesday, March 31 7:30 a.m.–1:30 p.m.


Posters are in place at all times when the Grand Hall is open. Authors will present their topic on Monday, March 30, from 7:30 a.m.–8:45 a.m. and 3:00 p.m.–4:00 p.m.
The following domestic and international posters will provide valuable research findings to treatment providers.

It Ain’t Me: Reducing the Impact of Implicit and Unconscious Provider Bias on OTP Patients
James Anderson, PA-C

The Methadone Education Project: Providing Resources for Community Providers
James Anderson, PA-C

An Evaluation of Pregnant & Postpartum Women Treatment Programs/ServicesThe Methadone Education Project: Providing Resources for Community Providers
Anton C. Bizzell, MD

Cannabis–The Anti-Gateway Drug
Angela Bonaguidi, LCSW

Utilization of Telemedicine to Treat Hepatitis C at a Medication-Assisted Opioid Treatment Program
Lawrence Brown, Jr., MD

Smoking or not Smoking Buprenorphine
Alice Deschenau, MD

Integrating Horticulture Therapy into an Opioid Treatment Program and Other Service Models
Kathryn Eggert, LCSW

InteCourse Target Audience:  Beginning, Intermediate & Advancedgrating Overdose Prevention into an Opioid Treatment Program
Scott Farnum, PhD(c)

How Strong is the Relationship Between Methadone Dose and QTc Interval?
Scot Fleshman, MSN

Reductions in Prescription Opioid Abuse among Enrollees into Opioid Treatment Programs
Chunki Fong, MS

Improving Self-Esteem Among Opiate Addicted Patients on MAT: A Six-Week Intervention
Bonnie Franckowiak, DNP

Integrating an Opioid Treatment Program into a Correctional Facility
Robert Freeman, BS

The Effects of Mothers’ Addiction and Substance Abuse on their Infant

Hamideh Jahangiri, MD

Pattern and Intensity of Smoking and Alcohol Drinking on Adolescents
Hamideh Jahangiri, MD

CBT Effect to Reduce Nicotine Dependence in Heavy Smoker Patients with Hypertension
Hamideh Jahangiri, MD

Integrated Care: Mental Health and MAT
Evan Kletter, PhD

Primary Care Integration
Michelle Kletter, BA

Age and Gender Distribution among Patients Entering Treatment for Opioid Addiction
Sarah Lavery, BS

Utilization of an Electronic Information System to Evaluate Practice at a Medication-Assisted OTP
Steven Kritz, MD

Community Based Overdose Prevention – Providing Naloxone in Methadone Maintenance Programming
Deborah Malatesta, LCSW

Challenges to Opioid Treatment Providers after Hurricane Sandy: Impact, Preparedness, and Recovery
Harlan Matusow, PhD

The Association of PHQ-9 & MDQ Scores with Lifetime Suicide Ideation & Attempt among Ageing Opioid-Dependent Individuals
Mary Mbaba, MPH

Decisions in Recovery: A Web-Based Shared Decision Making Tool for Medication-Assisted Treatment
Niki Miller, MS

Prevalence of Substance Abuse Among University Students 
Alireza Norouzi, PhD

Self-Reported Overdose Risks in a Sample of Patients Enrolled in an Opioid Treatment Program
K. Michelle Peavy, PhD

Risk Factor for Weight Gain during Methadone Maintenance Treatment
Einat Peles, PhD

Treatment of Chronic Hepatitis C in Drug Users: Ethical, Successful, and Useful

Andre Jean Remy, MD

Use of Opiates to Get High in Patients Seeking Replacement Therapy: Europe and the United States
Lorenzo Somaini, MD

Policy Considerations and Collaborative Partnerships: Working with Opioid Dependent Pregnant and Parenting Women
Nancy Young, PhD

Effects of Buprenorphine/Naloxone Dosing in Opioid-Dependent Medicaid Patients
Vladimir Zah, PhD(c)

Analysis of the ‘Revolving Door’ Effect in Opioid Dependent Patients from Medicaid Insurance Claims
Vladimir Zah, PhD(c)

An estimated 10 – 15 minutes is allocated for review of a maximum of 6 posters within 90 minutes for a total of 1.5 credit hours

Please click HERE for more information on continuing education credits for each section of the website.

Share This